A small interfering RNA targeting proteinase-activated receptor-2 is effective in suppression of tumor growth in a Panc1 xenograft model |
| |
Authors: | Iwaki Kentaro Shibata Kohei Ohta Masayuki Endo Yuichi Uchida Hiroki Tominaga Masayuki Okunaga Ryoki Kai Seiichiro Kitano Seigo |
| |
Affiliation: | Department of Surgery I, Oita University Faculty of Medicine, Oita, Japan. iwaki@ med.oita-u.ac.jp |
| |
Abstract: | Proteinase-activated receptor-2 (PAR-2), which is a G protein-coupled receptor, is activated in inflammatory processes and cell proliferation. We previously demonstrated that an anti-PAR-2 antibody suppresses proliferation of human pancreatic cells in vitro. However, there have been no studies of PAR-2 signaling pathways in vivo. The aim of this study was to determine whether blockade of PAR-2 by RNA interference influences pancreatic tumor growth. We originally constructed small interfering RNAs (siRNAs) targeting human PAR-2, and performed cell proliferation assays of Panc1 human pancreatic cancer cell line with these siRNAs. Intratumoral treatment with these PAR-2 siRNAs and atelocollagen was also performed in a xenograft model with nude mice and Panc1 cells. siRNAs against human PAR-2 inhibited proliferation of Panc1 cells, whereas control scramble siRNAs had no effect on proliferation. The PAR-2 siRNAs dramatically suppressed tumor growth in the xenograft model. PAR-2-specific siRNA inhibited growth of human pancreatic cancer cells both in vitro and in vivo. Blockade of PAR-2 signaling by siRNA may be a novel strategy to treat pancreatic cancer. |
| |
Keywords: | PAR‐2 pancreatic cancer trypsin tumor growth siRNA |
本文献已被 PubMed 等数据库收录! |
|